Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Nov 04 2025
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter Ended 30.09.2025.2. Limited Review Report For Quarter Ended 30.09.2025.3. Any Other Business With The Permission Of The Chair.
- Vista Pharmaceuticals Ltd. Press Release Oct 14 2025
- Vista Pharmaceuticals Ltd. Press Release Sep 30 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Later from Vista Pharmaceuticals
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 'Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd'
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2026
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.2. Limited Review Report Quarter And Nine Months 31.12.2025.3. Any Other Business With The Permission Of The Chair.
- Update on board meeting
- Vista Pharmaceuticals Ltd. Press Release Feb 05 2026
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals